YU43256B - Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one - Google Patents
Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-oneInfo
- Publication number
- YU43256B YU43256B YU525/82A YU52582A YU43256B YU 43256 B YU43256 B YU 43256B YU 525/82 A YU525/82 A YU 525/82A YU 52582 A YU52582 A YU 52582A YU 43256 B YU43256 B YU 43256B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- piperazinylalkyl
- phenoxyalkyl
- subst
- triazole
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/244,464 US4338317A (en) | 1981-03-16 | 1981-03-16 | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
Publications (2)
Publication Number | Publication Date |
---|---|
YU52582A YU52582A (en) | 1985-06-30 |
YU43256B true YU43256B (en) | 1989-06-30 |
Family
ID=22922879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU525/82A YU43256B (en) | 1981-03-16 | 1982-03-11 | Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one |
Country Status (26)
Country | Link |
---|---|
US (1) | US4338317A (de) |
JP (1) | JPS57159774A (de) |
KR (1) | KR880001374B1 (de) |
AT (1) | AT384022B (de) |
BE (1) | BE892503A (de) |
CA (1) | CA1198436A (de) |
CH (1) | CH649539A5 (de) |
CY (1) | CY1373A (de) |
DE (1) | DE3209557A1 (de) |
DK (1) | DK158728C (de) |
ES (1) | ES8305756A1 (de) |
FI (1) | FI73670C (de) |
FR (1) | FR2501690B1 (de) |
GB (1) | GB2096137B (de) |
GR (1) | GR76076B (de) |
HK (1) | HK4788A (de) |
IE (1) | IE52788B1 (de) |
IT (1) | IT1148137B (de) |
KE (1) | KE3711A (de) |
LU (1) | LU84011A1 (de) |
MX (1) | MX9203176A (de) |
NL (2) | NL190757C (de) |
SE (1) | SE447256B (de) |
SG (1) | SG30287G (de) |
YU (1) | YU43256B (de) |
ZA (1) | ZA821359B (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487773A (en) * | 1981-03-16 | 1984-12-11 | Mead Johnson & Company | 1,2,4-Triazol-3-one antidepressants |
US4386091A (en) * | 1982-02-24 | 1983-05-31 | Mead Johnson & Company | 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants |
AT388555B (de) * | 1983-06-29 | 1989-07-25 | Bristol Myers Co | Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten |
US4575555A (en) * | 1983-06-29 | 1986-03-11 | Mead Johnson & Company | 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative |
US4613600A (en) * | 1983-09-30 | 1986-09-23 | Mead Johnson & Company | Antidepressant 1,2,4-triazolone compounds |
YU44721B (en) * | 1983-11-30 | 1990-12-31 | Bristol Myers Co | Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone |
CA1248531A (en) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | 4-substituted piperazine-2-carboxylic acids |
US4784998A (en) * | 1987-04-06 | 1988-11-15 | Bristol-Myers Company | 1,3,4-oxadiazole pyschotropic compounds |
US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
US5256664A (en) * | 1992-04-28 | 1993-10-26 | Bristol-Myers Squibb Company | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
IT1256387B (it) * | 1992-11-13 | 1995-12-04 | Acraf | Procedimento per preparare triazoloni |
CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
EP0769297A1 (de) | 1995-10-17 | 1997-04-23 | Bristol-Myers Squibb Company | Verwendung von Nefazodon für die Herstellung eines Medikaments zur Behandlung von Panikanfällen |
CA2182241C (en) * | 1996-07-29 | 2002-09-17 | Bo Lei | Methods for the manufacture of nefazodone |
US5854248A (en) * | 1996-07-31 | 1998-12-29 | Bristol-Myers Squibb Company | Nefazodone: use in migraine prophylaxis |
US5852020A (en) * | 1996-11-22 | 1998-12-22 | Bristol-Myers Squibb Company | Nefazodone: use in treating post traumatic stress disorder |
US5735873A (en) * | 1996-12-19 | 1998-04-07 | Maclean; David S. | Surgical tool handle |
US5917050A (en) * | 1998-02-11 | 1999-06-29 | Bayer Corporation | Process for preparing alkoxytriazolinones |
ES2152860B1 (es) | 1998-10-23 | 2001-08-16 | Finaf 92 Sa | Forma cristalina de la nefazodona y procedimiento para su preparacion. |
US6706282B1 (en) | 1998-11-02 | 2004-03-16 | Evangeline Cruz | Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones |
JP2002541191A (ja) * | 1999-04-09 | 2002-12-03 | セプラコール, インク. | R−ヒドロキシネファゾドン |
US6586437B2 (en) | 1999-04-09 | 2003-07-01 | Sepracor Inc. | (S)-hydroxynefazodone antipsychotic therapy |
US6469008B2 (en) | 1999-04-09 | 2002-10-22 | Sepracor Inc. | (R)-hydroxynefazodone antipsychotic therapy |
EP1189616A2 (de) * | 1999-04-09 | 2002-03-27 | Sepracor Inc. | S-hydroxynefazodon |
CA2356450C (en) | 2001-09-10 | 2003-11-25 | Brantford Chemicals Inc. | An improved process for the preparation of nefazodone hydrochloride |
WO2003099265A2 (de) * | 2002-05-24 | 2003-12-04 | Coester Carl-Fr | Pharmazeutische wirkstoffkombination sowie deren verwendung |
GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
WO2004098283A2 (en) * | 2003-04-30 | 2004-11-18 | Fmc Corporation | Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
US7671072B2 (en) * | 2003-11-26 | 2010-03-02 | Pfizer Inc. | Aminopyrazole derivatives as GSK-3 inhibitors |
US20050233010A1 (en) * | 2004-04-19 | 2005-10-20 | Satow Philip M | Lithium combinations, and uses related thereto |
TW200612961A (en) * | 2004-05-18 | 2006-05-01 | Fmc Corp | Substituted cyclic urea derivatives |
CA2614289A1 (en) | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
EP2377530A3 (de) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation von Neurogenese durch PDE-Hemmung |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
EP2377531A2 (de) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080167363A1 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc | Modulation of Neurogenesis By Melatoninergic Agents |
AU2008204800A1 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
EP2183227B1 (de) * | 2007-08-07 | 2014-09-24 | Prosarix Limited | 1,2,4-triazolderivate als serotonerge modulatoren |
US9339500B2 (en) | 2008-03-04 | 2016-05-17 | Intra-Cellular Therapies, Inc. | Methods of treating vasomotor symptoms |
WO2009128058A1 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
TWI368512B (en) * | 2009-04-30 | 2012-07-21 | Univ Kaohsiung Medical | Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments |
WO2012072665A1 (en) | 2010-11-30 | 2012-06-07 | Pharmaneuroboost N.V. | Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors |
CN104402842A (zh) * | 2014-11-19 | 2015-03-11 | 苏州乔纳森新材料科技有限公司 | 一种哌嗪类药物中间体的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
IT1052119B (it) * | 1972-10-16 | 1981-06-20 | Sigma Tau Ind Farmaceuti | Derivati del triazolinone e procedimento per la loro preparazione |
-
1981
- 1981-03-16 US US06/244,464 patent/US4338317A/en not_active Expired - Lifetime
-
1982
- 1982-03-02 ZA ZA821359A patent/ZA821359B/xx unknown
- 1982-03-08 CA CA000397793A patent/CA1198436A/en not_active Expired
- 1982-03-09 GR GR67529A patent/GR76076B/el unknown
- 1982-03-11 NL NL8201021A patent/NL190757C/xx not_active IP Right Cessation
- 1982-03-11 YU YU525/82A patent/YU43256B/xx unknown
- 1982-03-12 FI FI820856A patent/FI73670C/fi not_active IP Right Cessation
- 1982-03-12 DK DK112582A patent/DK158728C/da not_active IP Right Cessation
- 1982-03-12 IT IT47978/82A patent/IT1148137B/it active Protection Beyond IP Right Term
- 1982-03-15 BE BE0/207574A patent/BE892503A/fr not_active IP Right Cessation
- 1982-03-15 CH CH1615/82A patent/CH649539A5/de not_active IP Right Cessation
- 1982-03-15 SE SE8201631A patent/SE447256B/sv not_active IP Right Cessation
- 1982-03-15 ES ES510449A patent/ES8305756A1/es not_active Expired
- 1982-03-15 LU LU84011A patent/LU84011A1/fr unknown
- 1982-03-15 CY CY137382A patent/CY1373A/xx unknown
- 1982-03-15 FR FR8204325A patent/FR2501690B1/fr not_active Expired
- 1982-03-15 IE IE589/82A patent/IE52788B1/en active Protection Beyond IP Right Term
- 1982-03-15 GB GB8207539A patent/GB2096137B/en not_active Expired
- 1982-03-16 DE DE19823209557 patent/DE3209557A1/de active Granted
- 1982-03-16 KR KR8201129A patent/KR880001374B1/ko active
- 1982-03-16 JP JP57040315A patent/JPS57159774A/ja active Granted
- 1982-03-16 AT AT0104582A patent/AT384022B/de not_active IP Right Cessation
-
1987
- 1987-03-27 SG SG302/87A patent/SG30287G/en unknown
- 1987-03-31 KE KE3711A patent/KE3711A/xx unknown
-
1988
- 1988-01-21 HK HK47/88A patent/HK4788A/xx not_active IP Right Cessation
-
1992
- 1992-06-23 MX MX9203176A patent/MX9203176A/es unknown
-
1997
- 1997-03-17 NL NL970014C patent/NL970014I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU52582A (en) | Process for producing subst.2-or 4-(phenoxylkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one | |
PH17914A (en) | Process for the production of new optically active 1,4-dihydropyridine compounds | |
PL239279A1 (en) | Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines | |
YU227682A (en) | Process for producing n-(4-(3-aminopropyl)-aminobutyl)-2-omega-guanidino-fatty acid-amindo)-2-subst.ethaneamide | |
DE3263757D1 (en) | Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles | |
AU520715B2 (en) | PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID | |
YU100381A (en) | Process for producing antiinflammatory 4,5-diaryl-alpha-(polyfluoralkyl)-1h-pyrrol-2-metamines | |
DE3272222D1 (en) | Process for producing 4-hydroxy-2,4,6,-trimethylcyclohexa-2,5-diene-1-one | |
ZA813111B (en) | Process for producing 2,3,5-trichloropyridine | |
SU913942A3 (en) | Process for producing 2,4-diamino-6-pyperidinopyrimidine-3-oxy (its modifications) | |
PT73016B (en) | Process for preparing novel substituted pyrazinyl-1,2,4-oxidiazoles | |
YU155383A (en) | Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethy-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8-one | |
IE800777L (en) | Producing 4-(pyridyl-2-oxy)phenoxy-alkanecarboxylic acid¹derivatives. | |
AU528874B2 (en) | A process for the preparation of 1,5-dimethylbicyclo (3.2.1) octanol-8 | |
YU43628B (en) | Process for producing 2- or 2,6-substituted penem compounds | |
JPS6450870A (en) | Novel process for manufacturing 1,2,4-triazole-3-one | |
AU544794B2 (en) | 4-(2,2-dialkyl-indane-1-ylidene)-piperidines | |
YU181084A (en) | Process for making 1,1-dioxopenicilano-iloxim ethyl-6-(2-amino-2-phenylacetamido) penicilanate | |
DE3267778D1 (en) | Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine | |
IT8121861V0 (it) | Dispositivo di chiusura simultanea dei due vani di una pressa per laproduzione di pannelli truciolari o fibrosi di legno o suoi succedanei. | |
GB2015517B (en) | Process for producing 3,5-dichloro- - methylstyrene | |
DE3161613D1 (en) | Process for the production of 3-mercapto-propanediol-(1,2) | |
YU284181A (en) | Process for obtaining 2,3-dihydro-pyrane | |
YU225981A (en) | Process for obtaining pharmaceutically active 4-(2-hydroxy-4-(subst.)phenyl)naphthalene-2-one | |
YU192682A (en) | Process for obtaining new 1,2,3-thiadiazole-5-yl-carbamides |